Close Menu

University of Texas Health Science Center at San Antonio

In Nucleic Acids Research this week: computational tool to uncover microbial traits from microbiome data, database of patient-derived xenograft from pediatric cancers, and more.

Researchers have used gene editing to reduce repetitive behaviors linked to autism in a mouse model of the condition, the Telegraph reports.

NEW YORK (GenomeWeb News) – A consortium led by the University of Texas Health Science Center at San Antonio has received a five-year award for up to $45 million from the US Department of Defense and US Department of Veterans Affairs to use next-generation sequencing and mass spectrometry to cond

The test is the latest of several Alzheimer's biomarker panels developed on Rules-Based Medicine's DiscoveryMAP platform. The company plans to develop a specialized assay for research use by next year with a lab-developed test potentially following shortly thereafter.

The deal is the first revenue-generating license for any technology developed at UTSA, and is the first multi-institution license secured through a regional tech-management office created last year to negotiate deals for four UT institutions in south Texas.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.